Long-term immunosuppression management: opportunities and uncertainties
D Wojciechowski, A Wiseman - … Journal of the American Society of …, 2021 - journals.lww.com
… Early withdrawal of corticosteroids remains an attractive … Perhaps a combination of low-dose
tacrolimus in combination … not only on the basis of traditional clinical and immunologic risk …
tacrolimus in combination … not only on the basis of traditional clinical and immunologic risk …
Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high‐dose glucocorticoid, tacrolimus, and cyclophosphamide in …
H Tsuji, R Nakashima, Y Hosono, Y Imura… - Arthritis & …, 2020 - Wiley Online Library
… The 6-month survival rate of patients undergoing conventional treatment with … The regimen
in this study involved introducing intensive immunosuppressive treatment in the early phase …
in this study involved introducing intensive immunosuppressive treatment in the early phase …
Immunosuppression trends in solid organ transplantation: the future of individualization, monitoring, and management
NA Pilch, LJ Bowman, DJ Taber - … : The Journal of Human …, 2021 - Wiley Online Library
… However, in these early studies using ATG preparations for induction in combination with …
Clinicians are eager to move beyond the traditional early 1-year outcomes and optimize long-…
Clinicians are eager to move beyond the traditional early 1-year outcomes and optimize long-…
Management of post‐transplant diabetes: immunosuppression, early prevention, and novel antidiabetics
… , analyzed together, PTDM based on HbA1c at 3 months post-transplantation was recently
… facilitate reversal of impaired glucose tolerance to normal glucose tolerance within 6-months …
… facilitate reversal of impaired glucose tolerance to normal glucose tolerance within 6-months …
COVID-19 in solid organ transplantation: a matched retrospective cohort study and evaluation of immunosuppression management
M Miarons, M Larrosa-Garcia, S Garcia-Garcia… - …, 2021 - journals.lww.com
… with normal activity transiently behave as poor metabolizers. … decreased and the
antiproliferative in combination (mammalian target of … Three (6.7%) patients were in the first 3 …
antiproliferative in combination (mammalian target of … Three (6.7%) patients were in the first 3 …
Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs
H Parlakpinar, M Gunata - Immunopharmacology and …, 2021 - Taylor & Francis
… Generally, in the first month after transplantation, a total of four doses are given at a dose
of 10 … dose of 500 mg, and average heart rates remained within the normal range [Citation177]. …
of 10 … dose of 500 mg, and average heart rates remained within the normal range [Citation177]. …
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre …
MME Jongsma, MA Aardoom, MA Cozijnsen… - Gut, 2022 - gut.bmj.com
… with moderate-to-severe luminal Crohn's disease under combined immunosuppression:
escalation versus early treatment. J Crohns Colitis 2016;10:1279–86.doi:10.1093/ecco-jcc/…
escalation versus early treatment. J Crohns Colitis 2016;10:1279–86.doi:10.1093/ecco-jcc/…
Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options
D Liu, SY Huang, JH Sun, HC Zhang, QL Cai… - Military Medical …, 2022 - Springer
… patients may die due to immunosuppression or due to reactivation of primary infection-induced
excessive inflammation early … -inflammatory balance and the normal functioning of innate …
excessive inflammation early … -inflammatory balance and the normal functioning of innate …
Benign COVID-19 in an immunocompromised cancer patient–the case of a married couple
V Spezzani, A Piunno, HU Iselin - Swiss medical weekly, 2020 - smw.ch
… of the disease has been a conundrum since the first severe acute respiratory syndrome (SARS)
corona … The haematogram showed normal haemoglobin and white blood cell count, with …
corona … The haematogram showed normal haemoglobin and white blood cell count, with …
[HTML][HTML] Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy
A Sokic-Milutinovic, T Milosavljevic - Digestive Diseases, 2024 - karger.com
… Patients with aggressive course of disease and risk factors for poor prognosis should be
treated with biologic therapy early, while conventional … in CD patients, together with the finding …
treated with biologic therapy early, while conventional … in CD patients, together with the finding …